These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
510 related items for PubMed ID: 17714123
1. High serum levels of antibodies against the recombinant 70 kDa ribonucleoprotein are useful for diagnosing mixed connective tissue disease. Salmhofer W, Hermann J, Joch M, Kerl H, Graninger W. J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1047-53. PubMed ID: 17714123 [Abstract] [Full Text] [Related]
2. Differentiation of RNP- and SM-antibody subsets in SLE and MCTD patients by a new ELISA using recombinant antigens. Gaubitz M, Wegmann C, Schotte H, Willeke P, Domschke W. Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):317-21. PubMed ID: 12030437 [Abstract] [Full Text] [Related]
3. Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases. Combe B, Rucheton M, Graafland H, Lussiez V, Brunel C, Sany J. Clin Exp Immunol; 1989 Jan; 75(1):18-24. PubMed ID: 2702772 [Abstract] [Full Text] [Related]
4. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases. Yamamoto AM, Amoura Z, Johannet C, Jeronimo AL, Campos H, Koutouzov S, Piette JC, Bach JF. Arthritis Rheum; 2000 Mar; 43(3):689-98. PubMed ID: 10728764 [Abstract] [Full Text] [Related]
6. Detection of autoantibodies in a quantitative immunoassay using recombinant ribonucleoprotein antigens. Habets WJ, Hoet MH, Sillekens PT, De Rooij DJ, Van de Putte LB, Van Venrooij WJ. Clin Exp Immunol; 1989 May; 76(2):172-7. PubMed ID: 2527098 [Abstract] [Full Text] [Related]
7. Clinical usefulness of antibodies to U1snRNP proteins in mixed connective tissue disease and systemic lupus erythematosus. Margaux J, Hayem G, Palazzo E, Chazerain P, De Bandt M, Haim T, Kahn MF, Meyer O. Rev Rhum Engl Ed; 1998 Jun; 65(6):378-86. PubMed ID: 9670329 [Abstract] [Full Text] [Related]
8. Quantitation of anti-RNP and anti-Sm antibodies in MCTD and SLE patients by immunoblotting. Habets WJ, de Rooij DJ, Hoet MH, van de Putte LB, van Venrooij WJ. Clin Exp Immunol; 1985 Feb; 59(2):457-66. PubMed ID: 3884199 [Abstract] [Full Text] [Related]
9. Improved serological differentiation between systemic lupus erythematosus and mixed connective tissue disease by use of an SmD3 peptide-based immunoassay. Mahler M, Stinton LM, Fritzler MJ. Clin Diagn Lab Immunol; 2005 Jan; 12(1):107-13. PubMed ID: 15642993 [Abstract] [Full Text] [Related]
10. Assays for Sm and RNP antibodies: pitfalls and technical considerations. Molden DP, Suzuki H, Nakamura RM. Diagn Immunol; 1985 Jan; 3(1):24-8. PubMed ID: 3922661 [Abstract] [Full Text] [Related]
11. [Clinical expression of systemic lupus erythematosus with anti-U1-RNP and anti-Sm antibodies]. López-Longo FJ, González Fernández CM, Rodríguez Mahou M, Grau Simó R, Monteagudo Sáez I, Meno García AC, Carreño Pérez L. Rev Clin Esp; 1997 May; 197(5):329-35. PubMed ID: 9280966 [Abstract] [Full Text] [Related]
12. Clinical significance of antibodies to TS1-RNA in patients with mixed connective tissue disease. Ikeda K, Takasaki Y, Hirokawa K, Takeuchi K, Hashimoto H. J Rheumatol; 2003 May; 30(5):998-1005. PubMed ID: 12734895 [Abstract] [Full Text] [Related]
13. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens. Damoiseaux J, Boesten K, Giesen J, Austen J, Tervaert JW. Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550 [Abstract] [Full Text] [Related]
14. Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease. Habets WJ, de Rooij DJ, Salden MH, Verhagen AP, van Eekelen CA, van de Putte LB, van Venrooij WJ. Clin Exp Immunol; 1983 Oct; 54(1):265-76. PubMed ID: 6352106 [Abstract] [Full Text] [Related]
16. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker. Simón JA, Cabiedes J, Ortiz E, Alcocer-Varela J, Sánchez-Guerrero J. Rheumatology (Oxford); 2004 Feb; 43(2):220-4. PubMed ID: 13130152 [Abstract] [Full Text] [Related]
17. Nonprecipitating IgG or IgM anti-Sm antibody: clinical significance and changes in immunoglobulin class. Tsuzaka K, Ogasawara T, Tojo T, Mimori T, Satoh M, Homma M. J Rheumatol; 1993 May; 20(5):822-30. PubMed ID: 7687702 [Abstract] [Full Text] [Related]
18. Serial estimation of anti-RNP antibody titers in systemic lupus erythematosus, mixed connective tissue disease and rheumatoid arthritis. Nishikai M, Okano Y, Mukohda Y, Sato A, Ito M. J Clin Lab Immunol; 1984 Jan; 13(1):15-9. PubMed ID: 6609234 [Abstract] [Full Text] [Related]
19. Clinical course of patients with anti-RNP antibodies. A prospective study of 32 patients. Lundberg I, Hedfors E. J Rheumatol; 1991 Oct; 18(10):1511-9. PubMed ID: 1765975 [Abstract] [Full Text] [Related]
20. Antiribonucleoprotein antibodies in children with human immunodeficiency virus infection: comparative study with childhood-onset systemic lupus erythematosus. González CM, López-Longo FJ, Monteagudo I, Grau R, Rodríguez-Mahou M, St-Cyr C, Lapointe N, Carreño L. Pediatr AIDS HIV Infect; 1996 Dec; 7(6):401-8. PubMed ID: 11361496 [Abstract] [Full Text] [Related] Page: [Next] [New Search]